COVID-19 vaccine export to resume

  • IASbaba
  • September 21, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

COVID-19 vaccine export to resume

Part of: Prelims and GS II – International Relations 

Context India will resume the export of COVID-19 vaccines under its ‘Vaccine Maitri’ programme to fulfil the commitment towards COVAX (COVID-19 Vaccines Global Access).

What is COVAX (COVID-19 Vaccines Global Access)?

  • The COVAX program is led by the vaccine alliance GAVI, WHO and the Coalition for Epidemic Preparedness Innovations (CEPI) in partnership with UNICEF, vaccine manufacturers and the World Bank, among others.
  • Aim: To ensure equitable distribution of COVID-19 vaccines globally 
  • It is supposed to be the largest vaccine procurement and supply operation in history.
  • The program wants to vaccinate roughly 20 percent of the population in the 92 Advance Market Commitment (AMC) countries, which include middle and lower-income nations that cannot afford to pay for COVID-19 vaccines. 
  • Countries with a Gross National Income (GNI) per capita of less than US $4000 and some other countries eligible under the World Bank International Development Association (IDA) shall be given top priority.

What is Gavi, the Vaccine Alliance?

  • It was Created in 2000.
  • Gavi is an international organisation – a global Vaccine Alliance, bringing together public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the world’s poorest countries.
  • Its core partners include the WHO, UNICEF, the World Bank and the Bill & Melinda Gates Foundation.

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....